Search Results - "Collisson, Eric"

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.

Authors: Collisson, Eric A. Sadanandam, Anguraj Olson, Peter et al.

Source: Nature Medicine. Apr2011, Vol. 17 Issue 4, p500-503. 4p. 4 Graphs.

Ferrous Iron-Dependent Pharmacology.

Authors: Gonciarz, Ryan L. Collisson, Eric A. Renslo, Adam R.

Source: Trends in Pharmacological Sciences. Jan2021, Vol. 42 Issue 1, p7-18. 12p.

This result is not displayed to guests.
Login for full access.

Single-molecule superresolution imaging allows quantitative analysis of RAF multimer formation and signaling.

Authors: Xiaolin Nan Collisson, Eric A. Lewis, Sophia et al.

Source: Proceedings of the National Academy of Sciences of the United States of America. 11/12/2013, Vol. 110 Issue 46, p18519-18524. 6p.

Subjects: Serine/threonine kinases, High resolution imaging, Growth factors, Cell membranes, Dimers

This result is not displayed to guests.
Login for full access.

Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.

Authors: Korkola, James E. Collisson, Eric A. Heiser, Laura et al.

Source: PLoS ONE. 7/16/2015, Vol. 10 Issue 7, p1-19. 19p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Active surrender.

Authors: Collisson, Eric A.¹ eric.collisson@ucsf.edu

Source: Pigment Cell & Melanoma Research. May2012, Vol. 25 Issue 3, p292-293. 2p.

Isoprenylation is Necessary for the Full Invasive Potential of RhoA Overexpression in Human Melanoma Cells.

Authors: Collisson, Eric A Carranza, Dafnis C Chen, Ingrid Y et al.

Source: Journal of Investigative Dermatology. Nov2002, Vol. 119 Issue 5, p1172-1176. 6p.

Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.

Authors: Korkola, James E. Collisson, Eric A. Heiser, Laura M. et al.

Source: PLoS ONE. 10/11/2017, Vol. 12 Issue 10, p1-1. 1p.

Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.

Authors: King, Gentry G. Baker, Kelsey K. Coveler, Andrew L. et al.

Source: Cancers. Jun2025, Vol. 17 Issue 11, p1830. 18p.

Blockchain-Authenticated Sharing of Genomic and Clinical Outcomes Data of Patients With Cancer: A Prospective Cohort Study.

Authors: Glicksberg, Benjamin Scott Burns, Shohei Currie, Rob et al.

Source: Journal of Medical Internet Research; Mar2020, Vol. 22 Issue 3, pN.PAG-N.PAG, 1p, 5 Charts

Pancreatic Cancer Genomics 2.0: Profiling Metastases.

Authors: Collisson, Eric A. Maitra, Anirban

Source: Cancer Cell. Mar2017, Vol. 31 Issue 3, p309-310. 2p.

AI-Driven insights in pancreatic cancer imaging: from pre-diagnostic detection to prognostication.

Authors: Antony, Ajith Mukherjee, Sovanlal Bi, Yan et al.

Source: Abdominal Radiology. Jul2025, Vol. 50 Issue 7, p3214-3224. 11p.

Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning.

Authors: Estevam, Gabriella O. Linossi, Edmond Jingyou Rao et al.

Source: eLife. 2/17/2025, p1-29. 29p.

Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V.

Authors: Gien, Lilian T. Song, Zihe Poklepovic, Andrew et al.

Source: JCO Precision Oncology. 12/12/2024, Vol. 8, p1-9. 9p.